Westlake Chemical (WLK)’s SVP – Chemical Manufacturing Andrew Kenner Unloaded 6028 shares of the Company; Omnicell (OMCL) Has 1.12 Sentiment

March 12, 2018 - By Hazel Jackson

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company has market cap of $1.76 billion. The firm operates through two divisions, Automation and Analytics, and Medication Adherence. It has a 85.66 P/E ratio. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

A calculated and well-grounded transaction was made by the SVP – Chemical Manufacturing of Westlake Chemical Corp, Mr. Andrew Kenner, on 12-03-2018, when he unloaded a sizable number of shares – 6,028, amounting to $723,360 U.S Dollars, calculated based on $120.0 per every share. In the last month, he also sold 24,318 shares with value $2,689,814 USD. Andrew reported this trade on 12-03-2018. The filing is accessible online here at the Security and Exchange Commission website. The massive transaction is sure to get stock market traders talking for the company. Andrew Kenner now holds 11,437 shares of the Firm.

Ratings analysis reveals 100% of Omnicell’s analysts are positive. Out of 2 Wall Street analysts rating Omnicell, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $44.0 while the high is $55.0. The stock’s average target of $49.50 is 9.03% above today’s ($45.4) share price. OMCL was included in 2 notes of analysts from December 6, 2016. The firm earned “Buy” rating on Thursday, January 19 by Dougherty & Company. As per Tuesday, December 6, the company rating was maintained by Benchmark.

Analysts await Omnicell, Inc. (NASDAQ:OMCL) to report earnings on May, 3. They expect $-0.04 earnings per share, up 86.21% or $0.25 from last year’s $-0.29 per share. After $0.28 actual earnings per share reported by Omnicell, Inc. for the previous quarter, Wall Street now forecasts -114.29% negative EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 2 insider sales for $279,557 activity.

The stock increased 2.25% or $1 during the last trading session, reaching $45.4. About 82,500 shares traded. Omnicell, Inc. (OMCL) has risen 33.21% since March 12, 2017 and is uptrending. It has outperformed by 16.51% the S&P500.

First Light Asset Management Llc holds 4.82% of its portfolio in Omnicell, Inc. for 298,219 shares. Daruma Capital Management Llc owns 1.22 million shares or 3.87% of their US portfolio. Moreover, Conestoga Capital Advisors Llc has 3.65% invested in the company for 1.62 million shares. The Minnesota-based Kopp Investment Advisors Llc has invested 3.36% in the stock. Summit Creek Advisors Llc, a Minnesota-based fund reported 229,374 shares.

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products. The company has market cap of $15.41 billion. It operates through two divisions, Olefins and Vinyls. It has a 11.91 P/E ratio. The Olefins segment offers ethylene, polyethylene, styrene monomer, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen.

Since February 22, 2018, it had 0 insider purchases, and 11 sales for $11.04 million activity. $2.19M worth of Westlake Chemical Corporation (NYSE:WLK) was sold by Buesinger Robert F. on Monday, March 5. Mangieri George J had sold 2,161 shares worth $245,079 on Monday, March 5. The insider Ederington L. Benjamin sold $773,665. $443,880 worth of Westlake Chemical Corporation (NYSE:WLK) was sold by Bender Mark Steven. 17,558 shares valued at $1.95M were sold by LUKENS MAX L on Thursday, February 22. Another trade for 9,351 shares valued at $1.05 million was made by Teel Lawrence E. on Monday, February 26. BLAKELY ROBERT T had sold 4,038 shares worth $448,218 on Tuesday, February 27.

Investors sentiment decreased to 1.33 in Q3 2017. Its down 0.05, from 1.38 in 2017Q2. It dropped, as 21 investors sold Westlake Chemical Corporation shares while 61 reduced holdings. 55 funds opened positions while 58 raised stakes. 37.12 million shares or 5.60% less from 39.33 million shares in 2017Q2 were reported. Tortoise Cap Advsrs Ltd Liability has 0% invested in Westlake Chemical Corporation (NYSE:WLK). Weiss Multi has invested 0.15% in Westlake Chemical Corporation (NYSE:WLK). Renaissance Techs Limited Liability Co has invested 0.01% in Westlake Chemical Corporation (NYSE:WLK). Bank & Trust Of Ny Mellon Corporation has invested 0.02% in Westlake Chemical Corporation (NYSE:WLK). Invesco Ltd owns 178,457 shares for 0.01% of their portfolio. Vanguard Gp reported 0.02% in Westlake Chemical Corporation (NYSE:WLK). Dimensional Fund Advsr L P holds 1.16 million shares. First Personal Financial Ser holds 0.01% or 468 shares. Ifc Inc Fl holds 0.05% of its portfolio in Westlake Chemical Corporation (NYSE:WLK) for 9,236 shares. Public Employees Retirement Association Of Colorado holds 0% or 1,120 shares in its portfolio. Arcadia Invest Mngmt Corporation Mi invested 0.01% of its portfolio in Westlake Chemical Corporation (NYSE:WLK). Cornerstone Capital Mgmt Liability Corp stated it has 0% of its portfolio in Westlake Chemical Corporation (NYSE:WLK). Sg Americas Limited Liability Com owns 8,649 shares. Moreover, Commercial Bank Of America De has 0% invested in Westlake Chemical Corporation (NYSE:WLK). Parallax Volatility Advisers Ltd Partnership accumulated 34 shares or 0% of the stock.

The stock decreased 0.74% or $0.89 during the last trading session, reaching $119.06. About 320,113 shares traded. Westlake Chemical Corporation (NYSE:WLK) has risen 45.05% since March 12, 2017 and is uptrending. It has outperformed by 28.35% the S&P500.

Among 18 analysts covering Westlake Chemical (NYSE:WLK), 11 have Buy rating, 2 Sell and 5 Hold. Therefore 61% are positive. Westlake Chemical has $139.0 highest and $52 lowest target. $101.31’s average target is -14.91% below currents $119.06 stock price. Westlake Chemical had 57 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Wells Fargo on Wednesday, January 17 with “Buy”. As per Friday, October 14, the company rating was initiated by Tudor Pickering. The firm has “Buy” rating by RBC Capital Markets given on Monday, September 18. RBC Capital Markets maintained the shares of WLK in report on Wednesday, August 5 with “Outperform” rating. The firm has “Buy” rating given on Thursday, January 25 by RBC Capital Markets. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. RBC Capital Markets maintained Westlake Chemical Corporation (NYSE:WLK) on Wednesday, December 13 with “Buy” rating. The rating was maintained by Deutsche Bank with “Hold” on Thursday, February 22. The firm earned “Neutral” rating on Monday, August 10 by Goldman Sachs. The company was maintained on Tuesday, October 17 by RBC Capital Markets.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts